[Skip header]
Patron: Her Majesty the Queen
RSSA coat of arms

The Royal Scottish Society of Arts
Showcasing Scotland's Science, Technology and Innovation

Home
Contacts Search
☰ Menu
Home About the Society Events Fellowship Governance Contacts Search

7th Meeting of the 198th Session (2018-2019)

The human genome - its scientific and societal impact

Professor Tim Aitman

Professor Tim Aitman

Professor Tim Aitman MB ChB FRCP FMedSci FRSB FRSE
Professor of Molecular Pathology and Genetics;
Director, Centre for Genomic & Experimental Medicine,
Institute of Genetics and Molecular Medicine,
Clinical Director, Edinburgh Genomics, University of Edinburgh; and
Honorary Consultant Physician, NHS Lothian

On Monday 29th April 2019, at 7pm

The first human draft sequence of the human genome was completed in 2001, a project taking 15 years and costing three billion dollars. An individual's human genome can now be sequenced in a few days at a cost of less than a thousand dollars. This lecture will consider the utility of this capability in genome sequencing to advance scientific knowledge and healthcare and will discuss whether society has fully understood and adapted to the power and opportunities of this technological revolution

Professor Tim Aitman is the Director of the Centre for Genomic and Experimental Medicine within the MRC Institute of Genetics and Molecular Medicine. He is Professor of Molecular Pathology and Genetics at the University of Edinburgh, Clinical Director of the whole genome sequencing facility in Edinburgh Genomics and Consultant Physician in NHS Lothian. He is a Fellow of the Royal Society of Edinburgh, the Royal College of Physicians, the Academy of Medical Sciences, and the Society of Biology and co-PI of the Scottish Genomes Partnership, a nationally important collaboration with the NHS and Genomics England. He was the Specialist Advisor for the 2009 House of Lords Inquiry in Genomic Medicine.

Professor Aitman’s research uses genome technology and information to elucidate the genetic basis of both common and rare human disorders, aiming to use this information to diagnose and stratify human disease, and to move such advances towards routine healthcare.